Arca
Skip to content

Limfa Therapy System (Limfa Therapy)

Stimulator, Muscle, Powered, For Muscle Conditioning. 510(k) K243165, from Eywa Srl (Rimini, IT). Product code NGX, class 2.

As of Nov 17, 2026, K243165 is an FDA 510(k) held by Eywa Srl, substantially equivalent on May 15, 2025 after 227 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 15, 2025
  • Review time: 227 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The indications for the Limfa Therapy System are to temporarily increase blood circulation in healthy leg muscles and to stimulate healthy muscles in order to improve and facilitate muscle performance.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other NGX Clearances

The newest 510(k)s for the same product code; their median review was 113 days; see every NGX device

Record

Type
Traditional
Received
Sep 30, 2024
Review panel
Physical Medicine
Regulation
21 CFR 890.5850

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.